STAT3 inhibitor 8q , CAS No.S613731, Inhibitor of signal transducer and activator of transcription 3

Item Number
S613731
Grouped product items
SKUSizeAvailabilityPrice Qty
S613731-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$570.90
S613731-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90

Basic Description

Specifications & PurityMoligand™
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of signal transducer and activator of transcription 3

Associated Targets(Human)

STAT3 Tchem Signal transducer and activator of transcription 3 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
STAT3 Tchem Signal transducer and activator of transcription 3 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
STAT3 Tchem Protein cereblon/STAT3 (98 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CT26 (928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name 4,9-dioxo-N-[2-(piperidin-1-yl)ethyl]-4H,9H-naphtho[2,3-b]furan-2-carboxamide
INCHI InChI=1S/C20H20N2O4/c23-17-13-6-2-3-7-14(13)18(24)19-15(17)12-16(26-19)20(25)21-8-11-22-9-4-1-5-10-22/h2-3,6-7,12H,1,4-5,8-11H2,(H,21,25)
InChi Key MLNGLWWCXHUBMT-UHFFFAOYSA-N
Canonical SMILES O=C(c1cc2c(o1)C(=O)c1c(C2=O)cccc1)NCCN1CCCCC1
Isomeric SMILES C1CCN(CC1)CCNC(=O)C2=CC3=C(O2)C(=O)C4=CC=CC=C4C3=O
PubChem CID 137321152

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, Niu G, Kay H, Mulé J, Kerr WG et al..  (2005)  Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity..  Nat Med,  11  (12): (1314-21).  [PMID:16288283]
2. Yuan J, Zhang F, Niu R.  (2015)  Multiple regulation pathways and pivotal biological functions of STAT3 in cancer..  Sci Rep,  (3): (17663).  [PMID:26631279]
3. Yu H, Lee H, Herrmann A, Buettner R, Jove R.  (2014)  Revisiting STAT3 signalling in cancer: new and unexpected biological functions..  Nat Rev Cancer,  14  (11): (736-46).  [PMID:25342631]
4. Jonker DJ, Nott L, Yoshino T, Gill S, Shapiro J, Ohtsu A, Zalcberg J, Vickers MM, Wei AC, Gao Y et al..  (2018)  Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial..  Lancet Gastroenterol Hepatol,  (4): (263-270).  [PMID:29397354]
5. Li C, Chen C, An Q, Yang T, Sang Z, Yang Y, Ju Y, Tong A, Luo Y.  (2019)  A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3)..  Eur J Med Chem,  162  (3): (543-554).  [PMID:30472602]
6. Hubbard JM, Grothey A.  (2017)  Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor..  Drugs,  77  (10): (1091-1103).  [PMID:28573435]

Solution Calculators